7.58
-0.06(-0.79%)
Currency In USD
| Previous Close | 7.64 |
| Open | 7.97 |
| Day High | 8.15 |
| Day Low | 7.58 |
| 52-Week High | 44.56 |
| 52-Week Low | 3.69 |
| Volume | 22,469 |
| Average Volume | 13,073 |
| Market Cap | 66.18M |
| PE | -0.37 |
| EPS | -20.22 |
| Moving Average 50 Days | 7.65 |
| Moving Average 200 Days | 9.41 |
| Change | -0.06 |
Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025
GlobeNewswire Inc.
Dec 17, 2024 1:05 PM GMT
TAMPA, FL, Dec. 17, 2024 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (the “Company”) (NASDAQ: SCNX), a specialty pharma company with a novel pipeline of brand products, is pleased to announce its participation in The Microcap Conference 2025, the
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
GlobeNewswire Inc.
Dec 10, 2024 1:05 PM GMT
COMMACK, NY and TAMPA, FL, Dec. 10, 2024 (GLOBE NEWSWIRE) -- SCIENTURE, LLC (“the “Company”), a wholly owned subsidiary of SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), focused on developing and commercializing novel branded, specialty pharma products,
Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement
GlobeNewswire Inc.
Nov 26, 2024 9:05 PM GMT
Scienture Holdings to Receive Funding of Up to $12 Million From Private Placement of 10% Secured Convertible Debentures and Up to $50 Million from Equity Line of Credit Tampa, FL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. (Nasdaq: